Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
318.7 NOK | -6.24% | -5.51% | -11.77% |
Apr. 26 | Nordic Shares Closed Up Friday; Medicover Series B Climbed Highest | DJ |
Apr. 26 | YARA INTERNATIONAL : Lower sales prices weigh on profitability |
Summary
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company appears to be poorly valued given its net asset value.
- The company is one of the best yield companies with high dividend expectations.
- Analyst opinion has improved significantly over the past four months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Agricultural Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.77% | 7.88B | A- | ||
+0.63% | 15.01B | B+ | ||
-21.27% | 13.81B | D+ | ||
+3.13% | 12.07B | C | ||
-15.34% | 9.73B | B+ | ||
-.--% | 7.3B | - | C- | |
-5.39% | 6.31B | - | ||
-5.36% | 3.93B | B- | ||
-28.77% | 2.37B | D | ||
+2.37% | 2.08B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- YAR Stock
- Ratings Yara International ASA